Companies / Saudi Arabia
SPIMACO to Establish API Facility
July 2006 | Company Finance AlertThe development of Saudi Arabia's APIs capacity is a significant step in developing a foreign presence. As active pharmaceutical ingredients must be sourced internationally - and are usually priced in US dollars or Euros - obtaining affordable inputs is a key consideration for the country's nascent manufacturing industry. Developing homegrown production is also likely to meet government objectives for self-sufficiency, at a time when a new US free trade deal is set to ramp up the pressure on domestic
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
